Human liver microsomal thiol methyltransferase: Inhibition by arylalkylamines

T. A. Glauser, E. Saks, V. M. Vasova, Richard M Weinshilboum

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

1. Thiol methyltransferase (TMT) is a microsomal enzyme catalyzing the S-methylation of aliphatic sulphydryl drugs and xenobiotics. Studies of the functional significance of S-methylation catalysed by TMT have been hampered by lack of a potent, relatively specific, non-toxic inhibitor of the enzyme. 2. Human hepatic microsomal TMT was inhibited by the arylalkylamine 2,3-dichloro-α;methylbenzylamine (DCMB), and by a series of arylalkylamines, as well as the arylamme, aniline. 3. Inhibition kinetic studies with DCMB, benzylamine, aniline, phenylethylamine and phenylethanolamine, five compounds with a wide range of IC50 values, showed 'mixed' inhibition of TMT with respect to the methyl acceptor substrate, 2-mercaptoethanol. Kis and Kii values were, respectively, 1.1 and 0.29 μM for DCMB, 160 μM each for benzylamine, 680 and 370 μM for aniline, 1640 and 1380 μM for phenylethylamine, and 2300 and 1400 μM for phenylethanolamine. Inhibition was at least partially reversible. 4. H.p.l.c. analyses were carried out with the products of enzyme reactions performed in the presence of aniline, benzylamine, and phenylethylamine to ascertain whether these compounds inhibited TMT by acting as methyl acceptors. Results showed that they did not act as methyl acceptor substrates.

Original languageEnglish (US)
Pages (from-to)657-669
Number of pages13
JournalXenobiotica
Volume23
Issue number6
DOIs
StatePublished - 1993

Fingerprint

thiol S-methyltransferase
Liver
Phenethylamines
Methylation
Mercaptoethanol
Enzyme Inhibitors
Xenobiotics
Substrates
Enzymes
Inhibitory Concentration 50
Kinetics
aniline

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Biochemistry
  • Health, Toxicology and Mutagenesis
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Human liver microsomal thiol methyltransferase : Inhibition by arylalkylamines. / Glauser, T. A.; Saks, E.; Vasova, V. M.; Weinshilboum, Richard M.

In: Xenobiotica, Vol. 23, No. 6, 1993, p. 657-669.

Research output: Contribution to journalArticle

Glauser, T. A. ; Saks, E. ; Vasova, V. M. ; Weinshilboum, Richard M. / Human liver microsomal thiol methyltransferase : Inhibition by arylalkylamines. In: Xenobiotica. 1993 ; Vol. 23, No. 6. pp. 657-669.
@article{7b9ed77f355740a58a1488a99e24d199,
title = "Human liver microsomal thiol methyltransferase: Inhibition by arylalkylamines",
abstract = "1. Thiol methyltransferase (TMT) is a microsomal enzyme catalyzing the S-methylation of aliphatic sulphydryl drugs and xenobiotics. Studies of the functional significance of S-methylation catalysed by TMT have been hampered by lack of a potent, relatively specific, non-toxic inhibitor of the enzyme. 2. Human hepatic microsomal TMT was inhibited by the arylalkylamine 2,3-dichloro-α;methylbenzylamine (DCMB), and by a series of arylalkylamines, as well as the arylamme, aniline. 3. Inhibition kinetic studies with DCMB, benzylamine, aniline, phenylethylamine and phenylethanolamine, five compounds with a wide range of IC50 values, showed 'mixed' inhibition of TMT with respect to the methyl acceptor substrate, 2-mercaptoethanol. Kis and Kii values were, respectively, 1.1 and 0.29 μM for DCMB, 160 μM each for benzylamine, 680 and 370 μM for aniline, 1640 and 1380 μM for phenylethylamine, and 2300 and 1400 μM for phenylethanolamine. Inhibition was at least partially reversible. 4. H.p.l.c. analyses were carried out with the products of enzyme reactions performed in the presence of aniline, benzylamine, and phenylethylamine to ascertain whether these compounds inhibited TMT by acting as methyl acceptors. Results showed that they did not act as methyl acceptor substrates.",
author = "Glauser, {T. A.} and E. Saks and Vasova, {V. M.} and Weinshilboum, {Richard M}",
year = "1993",
doi = "10.3109/00498259309059403",
language = "English (US)",
volume = "23",
pages = "657--669",
journal = "Xenobiotica",
issn = "0049-8254",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Human liver microsomal thiol methyltransferase

T2 - Inhibition by arylalkylamines

AU - Glauser, T. A.

AU - Saks, E.

AU - Vasova, V. M.

AU - Weinshilboum, Richard M

PY - 1993

Y1 - 1993

N2 - 1. Thiol methyltransferase (TMT) is a microsomal enzyme catalyzing the S-methylation of aliphatic sulphydryl drugs and xenobiotics. Studies of the functional significance of S-methylation catalysed by TMT have been hampered by lack of a potent, relatively specific, non-toxic inhibitor of the enzyme. 2. Human hepatic microsomal TMT was inhibited by the arylalkylamine 2,3-dichloro-α;methylbenzylamine (DCMB), and by a series of arylalkylamines, as well as the arylamme, aniline. 3. Inhibition kinetic studies with DCMB, benzylamine, aniline, phenylethylamine and phenylethanolamine, five compounds with a wide range of IC50 values, showed 'mixed' inhibition of TMT with respect to the methyl acceptor substrate, 2-mercaptoethanol. Kis and Kii values were, respectively, 1.1 and 0.29 μM for DCMB, 160 μM each for benzylamine, 680 and 370 μM for aniline, 1640 and 1380 μM for phenylethylamine, and 2300 and 1400 μM for phenylethanolamine. Inhibition was at least partially reversible. 4. H.p.l.c. analyses were carried out with the products of enzyme reactions performed in the presence of aniline, benzylamine, and phenylethylamine to ascertain whether these compounds inhibited TMT by acting as methyl acceptors. Results showed that they did not act as methyl acceptor substrates.

AB - 1. Thiol methyltransferase (TMT) is a microsomal enzyme catalyzing the S-methylation of aliphatic sulphydryl drugs and xenobiotics. Studies of the functional significance of S-methylation catalysed by TMT have been hampered by lack of a potent, relatively specific, non-toxic inhibitor of the enzyme. 2. Human hepatic microsomal TMT was inhibited by the arylalkylamine 2,3-dichloro-α;methylbenzylamine (DCMB), and by a series of arylalkylamines, as well as the arylamme, aniline. 3. Inhibition kinetic studies with DCMB, benzylamine, aniline, phenylethylamine and phenylethanolamine, five compounds with a wide range of IC50 values, showed 'mixed' inhibition of TMT with respect to the methyl acceptor substrate, 2-mercaptoethanol. Kis and Kii values were, respectively, 1.1 and 0.29 μM for DCMB, 160 μM each for benzylamine, 680 and 370 μM for aniline, 1640 and 1380 μM for phenylethylamine, and 2300 and 1400 μM for phenylethanolamine. Inhibition was at least partially reversible. 4. H.p.l.c. analyses were carried out with the products of enzyme reactions performed in the presence of aniline, benzylamine, and phenylethylamine to ascertain whether these compounds inhibited TMT by acting as methyl acceptors. Results showed that they did not act as methyl acceptor substrates.

UR - http://www.scopus.com/inward/record.url?scp=0027182238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027182238&partnerID=8YFLogxK

U2 - 10.3109/00498259309059403

DO - 10.3109/00498259309059403

M3 - Article

C2 - 8212739

AN - SCOPUS:0027182238

VL - 23

SP - 657

EP - 669

JO - Xenobiotica

JF - Xenobiotica

SN - 0049-8254

IS - 6

ER -